Effects of Endothelial Nitric Oxide Synthase, Interleukin-6 Gene Polymorphisms and Asymmetric Dimethylarginine Levels on Risk Factors and Lesion Sites in Peripheral Artery Disease

Author： Tuygun AK   Keser M   Tuygun A   Ketenci B   Şensöz Y   Balci AY   Karaci AR   Kizilay M   Yurtseven N   Yekeler İ  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.4, 2009-07, pp. : 1003-1010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roles of Cardiovascular Risk Factors in Endothelial Nitric Oxide Synthase Regulation: An Update

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3563-3578

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial nitric oxide synthase gene: prospects for treatment of heart disease

By Cooke Glen E   Doshi Amit   Binkley Philip F  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1723-1734

Future Medicine

Access to resources Recommend Favorite

The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 90-97

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism

By Wattanapitayakul S.K.   Mihm M.J.   Young A.P.   Bauer J.A.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 361-368

Elsevier

Access to resources Recommend Favorite

Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction

By  

Current Pharmaceutical Design, Vol. 11, Iss. 31, 2005-12 ,pp. : 4059-4067

Bentham Science Publishers

Access to resources Recommend Favorite